Table 1.
Bio-clinical data of the whole study population with comparison between survivors and non-survivors.
| Variables | Overall (n = 86) | Survivors (n = 51) | Deceased (n = 35) |
|---|---|---|---|
| Age (years) | 59.9 ± 14.0 | 52.6 ± 13.1 | 67.5 ± 8.6 |
| Male, n (%) | 38 (44.2) | 23 (45.1) | 15 (42.9) |
| Diabetes mellitus, n (%) | 35 (40.7) | 19 (37.3) | 16 (45.7) |
| Hypertension, n (%) | 39 (45.3) | 22 (43.1) | 17 (48.6) |
| Smoking, n (%) | 19 (22.1) | 5 (9.8) | 14 (40.0) |
| Systolic blood pressure (mmHg) | 135 ± 25 | 137 ± 25 | 129 ± 22 |
| Diastolic blood pressure (mmHg) | 76 ± 12 | 78 ± 13 | 72 ± 11 |
| Hemodialysis vintage (months) | 61.2 ± 53.2 | 58.9 ± 51.6 | 64.5 ± 56.1 |
| Alanine aminotransferase (IU/L) | 13.3 ± 10.2 | 15.5 ± 11.9 | 11.1 ± 6.2 |
| Albumin (g/dL) | 3.9 ± 0.5 | 4.0 ± 0.3 | 3.6 ± 0.5 |
| Total cholesterol (mg/dL) | 194.0 ± 49.3 | 195.2 ± 51.3 | 192.3 ± 47.1 |
| Triglyceride (mg/dL) | 210.0 ± 179.0 | 201.8 ± 170.5 | 212.0 ± 193.1 |
| Creatinine (mg/dL) | 10.3 ± 1.7 | 10.6 ± 1.8 | 9.9 ± 1.8 |
| Uric acid (mg/dL) | 7.3 ± 1.3 | 7.5 ± 1.4 | 7.1 ± 1.1 |
| Normalized protein catabolic rate (g/kg/day) | 1.1 ± 0.3 | 1.2 ± 0.3 | 0.9 ± 0.3 |
| Potassium (mmol/L) | 4.6 ± 0.9 | 4.6 ± 0.8 | 4.6 ± 1.0 |
| Adjusted calcium (mg/dL) | 9.2 ± 0.7 | 9.3 ± 0.7 | 9.1 ± 0.7 |
| Phosphate (mg/dL) | 4.4 ± 1.6 | 4.6 ± 1.7 | 4.3 ± 1.3 |
| Intact parathyroid hormone (pg/mL) | 150.9 ± 192.7 | 235.0 ± 32.9 | 98.3 ± 16.6 |
| Iron (μg/dL) | 79.4 ± 33.0 | 81.5 ± 34.7 | 74.4 ± 29.4 |
| Total iron binding capacity (μg/dL) | 230.0 ± 39.7 | 236.9 ± 40.6 | 226.1 ± 37.3 |
| Ferritin (ng/mL) | 623.0 ± 317.7 | 579.5 ± 286.7 | 665.1 ± 353.1 |
| Hemoglobin (g/dL) | 11.0 ± 1.0 | 10.7 ± 1.3 | 10.4 ± 1.5 |
| C-reactive protein (mg/dL) | 0.7 ± 1.0 | 0.6 ± 0.5 | 1.1 ± 1.2 |
| Galectin-3 (ng/mL) | 29.5 ± 10.3 | 25.5 ± 9.6 | 35.2 ± 8.6 |
| Vascular cell adhesion molecule 1 (ng/mL) | 1546.9 ± 331.8 | 1458.6 ± 303.7 | 1675.9 ± 332.8 |
Continuous variables were expressed as mean ± SD. Categorical variables are expressed as n (%). Boldface indicates where the values differ significantly between survivors and non-survivors.